Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aprise
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Aprise is a brand of cyproheptadine, a first-generation antihistamine with significant antiserotonergic and anticholinergic properties. Manufactured by Emcee Pharmaceuticals, it is primarily formulated as a 2mg syrup. The drug functions by antagonizing H1 histamine receptors to alleviate allergic symptoms such as sneezing, itching, and watery eyes. Additionally, its potent antagonism of 5-HT2 serotonin receptors in the hypothalamus makes it an effective appetite stimulant, used clinically to treat undernutrition, malnutrition, and failure to thrive. Due to its ability to cross the blood-brain barrier, common side effects include sedation, drowsiness, and dizziness. It is typically used with caution in patients with hepatic or renal impairment.
- Brand names
- Aprise
- Other names
- cyproheptadine hydrochloride
02
Targets
HTR2C (5-hydroxytryptamine 2C receptor)HTR2A (Serotonin receptor 5-HT2A)HTR2B (5-Hydroxytryptamine Receptor 2B)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Aprise.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aprise.